Herpes Zoster Plus
- Product NDC
- 43742-1296
- Requested package NDC
- 43742-1296-1
- 11-digit product format
- 437421296
- Labeler code
- 43742
- Product ID
- 43742-1296_b4a19c47-fbeb-4d62-b8c8-2b3e821030a7
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cistus Canadensis, Clematis Erecta, Croton Tiglium, Dolichos Pruriens, Iris Versicolor, Prunus Spinosa, Ranunculus Bulbosus, Kali Bichromicum, Zincum Phosphoratum, Arsenicum Album, Comocladia Dentata, Graphites, Kalmia Latifolia, Lachesis Mutus, Mezereum, Rhus Tox, Thallium Metallicum
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2019-05-14
- Marketing end
- 2025-03-03
- Substance
- HELIANTHEMUM CANADENSE; CLEMATIS RECTA FLOWERING TOP; CROTON TIGLIUM SEED; MUCUNA PRURIENS FRUIT TRICHOME; IRIS VERSICOLOR ROOT; PRUNUS SPINOSA FLOWER BUD; RANUNCULUS BULBOSUS; POTASSIUM DICHROMATE; ZINC PHOSPHIDE; ARSENIC TRIOXIDE; COMOCLADIA DENTATA BARK/LEAF; GRAPHITE; KALMIA LATIFOLIA LEAF; LACHESIS MUTA VENOM; DAPHNE MEZEREUM BARK; TOXICODENDRON PUBESCENS LEAF; THALLIUM
- Active strength
- 6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 43742-1296 | 43742-1296-1 | D | Discontinued by firm | 2026-10-02 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43742-1296-1 | 43742129601 | 30 mL in 1 BOTTLE, DROPPER (43742-1296-1) | 30 ml | 2019-05-14 | 2025-03-03 | No | No | Current |